Interleukin-2-inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients (Q41682990)

30 June 2018

title

Interleukin-2-inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients (English)

1 reference

Crossref

https://api.crossref.org/works/10.1111/J.1349-7006.1991.TB01908.X

21 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.1991.TB01908.X

21 October 2022

author name string

S. Sone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

E. Kunishige

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

F. Fawzy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

H. Yanagawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

A. Nii

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

K. Maeda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

S. Atagi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

Y. Heike

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

Y. Nishioka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

K. Mizuno

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

21 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1649813

21 October 2022

publication date

1 June 1991

1 reference

30 June 2018

number of pages

8

1 reference

full work available at URL

inferred from page(s)

https://europepmc.org/articles/PMC5918506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

https://europepmc.org/articles/PMC5918506?pdf=render

21 October 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649813

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.1991.tb01908.x

21 October 2022

1 reference

Crossref

https://api.crossref.org/works/10.1111/J.1349-7006.1991.TB01908.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1991.tb01908.x/fullpdf

21 October 2022

1 reference

Crossref

https://api.crossref.org/works/10.1111/J.1349-7006.1991.TB01908.X

Japanese Journal of Cancer Research

21 October 2022

published in

1 reference

30 June 2018

volume

82

1 reference

30 June 2018

issue

6

1 reference

30 June 2018

page(s)

716-723

1 reference

30 June 2018

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

Immunologic alterations in bronchogenic cancer. Sequential study

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

A system for the clinical staging of lung cancer

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

Heterogeneity of human lymphokine (IL-2)-activated killer (LAK) precursors and regulation of their LAK induction by blood monocytes.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

Interleukin 2-activated killer cells: generation in collaboration with interferon gamma and its suppression in cancer patients

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

Antitumour potential of pleural cavity macrophages in lung cancer patients without malignant effusion

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918506

Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients

18 August 2018

1 reference

12 December 2020

Admission criteria for immunogerontological studies in man: the SENIEUR protocol

1 reference

12 December 2020

Detection of cytotoxicity of freshly obtained lymphocytes and of lymphocytes activated with recombinant interleukin II (rIL-2) against lung cancer cell lines by human tumor clonogenic assay (HTCA)

1 reference

12 December 2020

Mechanisms of age-related decline in antigen-specific T cell proliferative response: IL-2 receptor expression and recombinant IL-2 induced proliferative response of purified Tac-positive T cells

1 reference

12 December 2020

1 reference

12 December 2020

Natural killer cell activity in lung cancer patients

1 reference

12 December 2020

Effects of human alveolar macrophages on the induction of lymphokine (IL 2)-activated killer cells

1 reference

12 December 2020

T-lymphocyte subsets in smoking and lung cancer: Analysis of monoclonal antibodies and flow cytometry

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Lymphokine-activated killer (LAK) cell activity in tumor-infiltrating lymphocytes from non-small cell lung cancer

1 reference

12 December 2020

Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity

1 reference

12 December 2020

Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response

1 reference

12 December 2020

Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells

1 reference

12 December 2020

Diminished lymphocyte responses to phytohemagglutinin in lung cancer

1 reference

12 December 2020

Failure of cell-mediated effector mechanisms in lung cancer

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients

1 reference

12 December 2020

Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma

1 reference

12 December 2020

A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma

1 reference

12 December 2020

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta

1 reference

12 December 2020

Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer

1 reference

12 December 2020

Identifiers

1 reference

30 June 2018

PMC publication ID

5918506

1 reference

30 June 2018

1 reference

30 June 2018